Q2 2021 Transgene SA Earnings Call Transcript
Hello and welcome to the Transgene First Half 2021 Financial Results and Business Update. My name is Jess and I'll be your coordinator for today's event.
(Operator Instructions)
I will now hand you over to your host, Lucie Larguier to begin today's call. Thank you.
Thank you Jess. So I'm Lucie, Director of IR at Transgene. During our call today Hedi Ben Brahim, Chairman and CEO of Transgene will provide you with a short overview of the important progress we have made during the period. After that Jean-Philippe Del, Chief Financial Officer; Eric Quemeneur, Chief Scientific Officer; and Maud Brandely, Chief Medical Officer will be available to answer all your questions.
Before I turn the call over to Mr. Ben Brahim, I would like to remind everyone that today's discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. The webcast can be accessed via the Investor page of our website, and via the press release issued
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
